Duodenal Ulcer
📧 Sign up to get email alerts when something new happens for Duodenal Ulcer.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-12-20FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Supplemental Application (Oceanside Pharmaceuticals)
The FDA approved a supplemental application for the combination product Omeprazole and Sodium Bicarbonate from Oceanside Pharmaceuticals.
-
FDA approval · 2013-12-10FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for pantoprazole sodium (generic) submitted by Lannett Company, Inc., indicating an additional regul…
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Helicobacter Pylori Eradication Treatment in Patients With Duodenal Ulcers
This clinical trial update reports a completed study evaluating Helicobacter pylori eradication treatment in patients with duodenal ulcers.
-
FDA approval · 2013-11-08FDA Approved: RABEPRAZOLE SODIUM — Original Application (Lannett Company, Inc.)
FDA approved the original application for rabeprazole sodium from Lannett Company, Inc., enabling a generic version of the proton pump inhib…
-
FDA approval · 2013-11-08FDA Approved: RABEPRAZOLE SODIUM — Original Application (Torrent Pharmaceuticals Limited)
FDA approves Torrent Pharmaceuticals Limited's original application for generic rabeprazole sodium, a proton pump inhibitor indicated for ga…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-10-31FDA Approved: OMEPRAZOLE MAGNESIUM — Supplemental Application (Gericare Pharmaceuticals)
The FDA approved a supplemental application for omeprazole magnesium from Gericare Pharmaceuticals, granting approval for a generic product …
-
CLINICAL_TRIALS trial_result · 2013-09-25Clinical Trial Update: Comparative Study of Autologous Blood Injection Versus Diluted Epinephrine in Treating Actively Bleeding Gastroduodenal Ulcers [NA]
This completed clinical trial compares autologous blood injection with diluted epinephrine for the treatment of actively bleeding gastroduod…
-
FDA label_change · 2013-09-13FDA Approved: GOOD NEIGHBOR PHARMACY OMEPRAZOLE — Supplemental Application (Amerisource Bergen)
The FDA lists a supplemental application for Good Neighbor Pharmacy Omeprazole (omeprazole) from AmerisourceBergen, typically related to lab…
-
FDA approval · 2013-08-27FDA Approved: LANSOPRAZOLE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Lansoprazole from Mylan Pharmaceuticals Inc., resulting in approval of a generic Lansoprazol…
-
CLINICAL_TRIALS research · 2013-08-21Clinical Trial Update: Sublingual Administration of PPI
A clinical trial is evaluating sublingual administration of a proton pump inhibitor for gastric or duodenal ulcers; the status of the study …
-
CLINICAL_TRIALS trial_result · 2013-08-20Clinical Trial Update: Efficacy and Safety of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Duodenal Ulcer [Phase 3]
A Phase 3 trial comparing TAK-438 (vonoprazan) to lansoprazole (AG-1749) for the treatment of duodenal ulcers has completed, evaluating effi…
-
FDA approval · 2013-08-16FDA Approved: GOOD NEIGHBOR PHARMACY OMEPRAZOLE — Supplemental Application (Amerisource Bergen)
FDA approved a supplemental application for Good Neighbor Pharmacy's omeprazole, enabling changes to the previously approved labeling for th…
-
FDA approval · 2013-08-06FDA Approved: ESOMEPRAZOLE STRONTIUM — Original Application (R2 Pharma, LLC)
FDA approved esomeprazole strontium via the Original Application (NDA202342) for indications consistent with proton pump inhibitors (GERD-re…
-
FDA approval · 2013-06-30FDA Approved: OMEPRAZOLE — Supplemental Application (Apotex Corp)
FDA approved a supplemental application for Omeprazole from Apotex Corp, confirming approval of a supplemental filing for this generic proto…
-
FDA approval · 2013-06-13FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (NorthStar Rx LLC)
The FDA approved a supplemental application for pantoprazole sodium from NorthStar Rx LLC, indicating an approved change to an existing pant…
-
FDA approval · 2013-05-30FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for pantoprazole sodium submitted by Torrent Pharmaceuticals Limited (generic pantoprazole) under an…
-
FDA approval · 2013-04-19FDA Approved: ACIPHEX — Supplemental Application (Waylis Therapeutics LLC)
FDA approved a supplemental application for ACIPHEX (rabeprazole sodium) submitted by Waylis Therapeutics LLC. The action expands or updates…
-
FDA approval · 2013-04-19FDA Approved: OMEPRAZOLE/SODIUM BICARBONATE — Original Application (Strides Pharma Science Limited)
FDA approved Strides Pharma Science Limited's generic omeprazole/sodium bicarbonate (original application) for use as a proton pump inhibito…
-
FDA approval · 2013-04-05FDA Approved: BASIC CARE LANSOPRAZOLE — Supplemental Application (Amazon.com Services LLC)
FDA approved a supplemental application for BASIC CARE LANSOPRAZOLE (lansoprazole) from Amazon.com Services LLC, a generic lansoprazole prod…
-
FDA approval · 2013-04-01FDA Approved: PEPCID AC MAXIMUM STRENGTH — Supplemental Application (Kenvue Brands LLC)
The FDA approved a supplemental application for Pepcid AC Maximum Strength (famotidine) by Kenvue Brands LLC.
-
FDA approval · 2013-03-04FDA Approved: SUCRALFATE — Supplemental Application (Mylan Pharmaceuticals, Inc.)
FDA approved a supplemental application for SUCRALFATE submitted by Mylan Pharmaceuticals, Inc.
-
FDA approval · 2013-03-04FDA Approved: CARAFATE — Supplemental Application (Allergan, Inc.)
The FDA approved Allergan's supplemental application for Carafate (sucralfate). This action updates the labeling and approved uses based on …
-
FDA approval · 2013-02-22FDA Approved: FAMOTIDINE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved a supplemental application for famotidine submitted by Alembic Pharmaceuticals Inc.
-
FDA approval · 2013-02-11FDA Approved: NIZATIDINE — Supplemental Application (Epic Pharma, LLC)
FDA approved Epic Pharma, LLC's supplemental application to market a generic nizatidine product (an H2 receptor blocker) under an ANDA, expa…
-
FDA approval · 2013-01-23FDA Approved: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE — Supplemental Application (H2-Pharma, LLC)
FDA approved a supplemental application for the fixed-dose combination of bismuth subcitrate potassium, metronidazole, and tetracycline hydr…